NoVax4Me vs Bryan | 164–152 | 51.90% |
NoVax4Me vs Kazuya | 147–166 | 46.96% |
NoVax4Me vs Reina | 171–142 | 54.63% |
NoVax4Me vs King | 141–131 | 51.84% |
NoVax4Me vs Hwoarang | 139–130 | 51.67% |
NoVax4Me vs Steve | 130–137 | 48.69% |
NoVax4Me vs Jin | 141–120 | 54.02% |
NoVax4Me vs Law | 94–99 | 48.70% |
NoVax4Me vs Lili | 81–97 | 45.51% |
NoVax4Me vs Yoshimitsu | 73–101 | 41.95% |
NoVax4Me vs Lars | 82–88 | 48.24% |
NoVax4Me vs Dragunov | 71–90 | 44.10% |
NoVax4Me vs Jun | 77–79 | 49.36% |
NoVax4Me vs Lee | 67–86 | 43.79% |
NoVax4Me vs Paul | 80–71 | 52.98% |
NoVax4Me vs Azucena | 68–67 | 50.37% |
NoVax4Me vs Xiaoyu | 54–74 | 42.19% |
NoVax4Me vs Devil Jin | 55–69 | 44.35% |
NoVax4Me vs Asuka | 49–64 | 43.36% |
NoVax4Me vs Victor | 45–65 | 40.91% |
NoVax4Me vs Eddy | 48–52 | 48.00% |
NoVax4Me vs Raven | 39–54 | 41.94% |
NoVax4Me vs Heihachi | 46–45 | 50.55% |
NoVax4Me vs Lidia | 34–56 | 37.78% |
NoVax4Me vs Feng | 47–41 | 53.41% |
NoVax4Me vs Nina | 41–47 | 46.59% |
NoVax4Me vs Alisa | 41–44 | 48.24% |
NoVax4Me vs Leroy | 39–39 | 50.00% |
NoVax4Me vs Jack-8 | 32–44 | 42.11% |
NoVax4Me vs Claudio | 36–35 | 50.70% |
NoVax4Me vs Zafina | 33–36 | 47.83% |
NoVax4Me vs Leo | 38–30 | 55.88% |
NoVax4Me vs Kuma | 30–32 | 48.39% |
NoVax4Me vs Clive | 22–31 | 41.51% |
NoVax4Me vs Shaheen | 22–26 | 45.83% |
NoVax4Me vs Panda | 5–6 | 45.45% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.